NO20000330L - FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein - Google Patents

FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Info

Publication number
NO20000330L
NO20000330L NO20000330A NO20000330A NO20000330L NO 20000330 L NO20000330 L NO 20000330L NO 20000330 A NO20000330 A NO 20000330A NO 20000330 A NO20000330 A NO 20000330A NO 20000330 L NO20000330 L NO 20000330L
Authority
NO
Norway
Prior art keywords
lipid
protein
articles
procedure
production
Prior art date
Application number
NO20000330A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000330D0 (no
Inventor
Matthias Andersson
Dorota Johansson
Percy Li
Bjoern Norrlind
Bengt Westgren
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of NO20000330D0 publication Critical patent/NO20000330D0/no
Publication of NO20000330L publication Critical patent/NO20000330L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
NO20000330A 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein NO20000330L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702776A SE9702776D0 (sv) 1997-07-22 1997-07-22 Method of preparing pharmaceutical compositions
PCT/SE1998/001407 WO1999004761A1 (en) 1997-07-22 1998-07-22 Method of preparing pharmaceutical compositions of lipid particles comprising a lipid agent and a protein

Publications (2)

Publication Number Publication Date
NO20000330D0 NO20000330D0 (no) 2000-01-21
NO20000330L true NO20000330L (no) 2000-03-21

Family

ID=20407807

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000330A NO20000330L (no) 1997-07-22 2000-01-21 FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein

Country Status (12)

Country Link
EP (1) EP1014947B1 (de)
JP (1) JP3813439B2 (de)
AT (1) ATE289806T1 (de)
AU (1) AU744738B2 (de)
CA (1) CA2297924C (de)
DE (1) DE69829191T2 (de)
ES (1) ES2236919T3 (de)
NO (1) NO20000330L (de)
NZ (1) NZ502840A (de)
PT (1) PT1014947E (de)
SE (1) SE9702776D0 (de)
WO (1) WO1999004761A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2689696C (en) 1999-02-26 2013-08-06 Novartis Vaccines And Diagnostics, Inc. Microemulsions with adsorbed macromolecules and microparticles
WO2001045761A1 (en) * 1999-12-22 2001-06-28 Surgical Sealants, Inc. Methods and compositions for sealing tissue leaks
HUP0200750A3 (en) * 2000-02-02 2005-02-28 Univ Florida State Res Found C10 heterosubstituted acetate taxanes as antitumor agents and pharmaceutical compositions containing them and their use
US6514523B1 (en) * 2000-02-14 2003-02-04 Ottawa Heart Institute Research Corporation Carrier particles for drug delivery and process for preparation
JP5102423B2 (ja) * 2000-04-20 2012-12-19 オバン・エナジー・リミテッド 改善された水不溶性薬剤粒子の処理
US6599441B1 (en) * 2000-07-18 2003-07-29 Emerald Biostructures, Inc. Crystallization solutions
US7803400B2 (en) 2002-12-03 2010-09-28 Blanchette Rockefeller Neurosciences Institute Artificial low-density lipoprotein carriers for transport of substances across the blood-brain barrier
KR101186210B1 (ko) 2002-12-03 2012-10-08 블랜체트 록펠러 뉴로사이언시즈 인스티튜트 혈뇌장벽을 통과하는 물질 수송용 인공 저밀도 지단백질 운반체
PT1613346E (pt) 2003-04-04 2013-01-29 Pah Usa 15 Llc Emulsões óleo-em-água microfluidificadas e composições de vacinas
WO2006082824A1 (ja) * 2005-02-03 2006-08-10 Nrl Pharma, Inc. マトリックス型腸溶性・徐放性組成物
KR100902570B1 (ko) * 2005-03-28 2009-06-11 주식회사 리제론 단백질을 포위하는 나노리포좀의 제조방법 및 단백질-포위나노리포좀
JP2009522554A (ja) * 2005-12-29 2009-06-11 ライフ テクノロジーズ コーポレーション ポリアクリルアミドゲル上で分離される生体分子の分解能を改善するための組成物および方法
EP1915986A1 (de) * 2006-10-23 2008-04-30 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Wachstumsfaktorhaltige Lipidformulierungen
CH715456B1 (de) 2007-04-27 2020-04-30 Mibelle Ag Kosmetisches Produkt zur topischen Anwendung für den Schutz und die Erneuerung von Hautstammzellen, welches sich von dedifferenzierten Pflanzenzellen ableitet.
US8071759B2 (en) 2008-07-18 2011-12-06 Affymetrix, Inc. Water soluble cholesterol derivatives
WO2010057203A2 (en) 2008-11-17 2010-05-20 The Board Of Regents Of The University Of Texas System Hdl particles for delivery of nucleic acids
EP2474306B1 (de) 2009-08-31 2016-11-09 NanoCarrier Co., Ltd. Partikelzusammensetzung und medizinische vorrichtung damit
US20160346219A1 (en) 2015-06-01 2016-12-01 Autotelic Llc Phospholipid-coated therapeutic agent nanoparticles and related methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
IL86799A (en) * 1987-07-02 1993-03-15 Kabi Pharmacia Ab Method and device for injection
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
US5652339A (en) * 1993-12-31 1997-07-29 Rotkreuzstiftung Zentrallaboratorium Method of producing reconstituted lipoproteins

Also Published As

Publication number Publication date
NO20000330D0 (no) 2000-01-21
NZ502840A (en) 2002-08-28
JP3813439B2 (ja) 2006-08-23
AU744738B2 (en) 2002-02-28
JP2001510786A (ja) 2001-08-07
CA2297924A1 (en) 1999-02-04
DE69829191D1 (de) 2005-04-07
AU8371898A (en) 1999-02-16
EP1014947B1 (de) 2005-03-02
ATE289806T1 (de) 2005-03-15
SE9702776D0 (sv) 1997-07-22
DE69829191T2 (de) 2005-07-21
PT1014947E (pt) 2005-05-31
ES2236919T3 (es) 2005-07-16
WO1999004761A1 (en) 1999-02-04
CA2297924C (en) 2007-04-10
EP1014947A1 (de) 2000-07-05

Similar Documents

Publication Publication Date Title
NO20000330L (no) FremgangsmÕte ved fremstilling av farmasøytiske sammensetninger av lipidartikler omfattende et lipidstoff og et protein
AU649973B2 (en) Aromatic amine compounds, their method of preparation and pharmaceutical compositions in which they are present
CZ58196A3 (en) Naphthyl derivative, process of its preparation, pharmaceutical composition containing and intermediate for preparing thereof
DE69802005D1 (de) Kombination aus prolaminen und polaren pflanzlichen lipiden, verfahren zu deren herstellung sowie deren verwendungen
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
ATE34078T1 (de) Arzneiform zur oralen verabreichung sowie verfahren zu deren herstellung durch gefriertrocknen einer oel-in-wasser-emulsion.
NO175240C (no) Fremgangsmåte for fremstilling av et langsomt frigivende farmasöytisk preparat som omfatter sekundære granuler
HUT38892A (en) Process for preparing alpha-, omega-dicarboxylic acids and pharmaceutical compositions comprising the same as active substance
ZA961898B (en) Novel melatonin-antagonist beta-carboline derivatives and analogues thereof containing naphthalenic structure process for their preparation and their medicinal products
IL94278A0 (en) 2-saccharine derivatives,their preparation and pharmaceutical compositions containing them
IL83357A (en) Renin-inhibiting peptides, process for their preparation, pharmaceutical compositions containing them, and their use
DE3767998D1 (de) Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
HUP9700826A1 (hu) Peptikus fekély elleni gyógyászati készítmények
NO965388L (no) Fremgangsmåte og apparat for fremstilling av raskt opplöselige doseenheter og produkter derav
GR900100772A (el) Μέ?οδος για την παρασκευή φαρμακευτικών σκευασμάτων.
AU583255B2 (en) New benzenesulfonyl-lactams, process for their preparation and their use as active substances of pharmaceutical compositions
AU586410B2 (en) New cyclic benzenesulfonamides, process for their preparation and their use as active substance of pharmaceutical compositions
ATE60889T1 (de) Rekonstituiertes nahrungsmittel, verfahren und mischer zu seiner herstellung.
HUT44764A (en) Process for producing new sulfonamidoethyl derivatives and pharmaceutical preparations comprising them as active substance
DK0740547T3 (da) Liposomer indeholdende deri indkapslede proteiner, fremgangsmåde til deres fremstilling, samt farmaceutiske og kosmetiske p
GR3034886T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation and their use in the production of pharmaceutical preparations as well as pharmaceutical preparations containing them
JPH10109924A (ja) 美白化粧品
SE8405118L (sv) 4-kloro-furo-(3,4-c)-pyridin-derivat forfarande for framstellning derav och terapeutiska kompositioner innehallande dem
MA26656A1 (fr) Nouveaux 19-nor steroides 17-halogenes, procede et intermediares de preparation, application comme medicaments et compositions pharmaceutiques les renfermant
AU5001790A (en) New 1-arylsulphonyl-2-pyrrolidinethione or 1-arylsulphonyl-2 -piperidinethione derivatives, process for the preparation thereof, their application as medicinal products and compositions containing them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application